Your browser doesn't support javascript.
loading
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab.
Blauvelt, Andrew; Shi, Nianwen; Burge, Russel; Malatestinic, William N; Lin, Chen-Yen; Lew, Carolyn R; Zimmerman, Nicole M; Goldblum, Orin M; Zhu, Baojin; Murage, Mwangi J.
  • Blauvelt A; Oregon Medical Research Center, Portland, Oregon.
  • Shi N; IBM Watson Health, Cambridge, Massachusetts.
  • Burge R; Eli Lilly and Company, Indianapolis, Indiana; University of Cincinnati, Division of Pharmaceutical Sciences, Winkle College of Pharmacy, Cincinnati, Ohio.
  • Malatestinic WN; Eli Lilly and Company, Indianapolis, Indiana.
  • Lin CY; Eli Lilly and Company, Indianapolis, Indiana.
  • Lew CR; IBM Watson Health, Cambridge, Massachusetts.
  • Zimmerman NM; IBM Watson Health, Cambridge, Massachusetts.
  • Goldblum OM; Eli Lilly and Company, Indianapolis, Indiana.
  • Zhu B; Eli Lilly and Company, Indianapolis, Indiana.
  • Murage MJ; Eli Lilly and Company, Indianapolis, Indiana. Electronic address: murage_mwangi_james@lilly.com.
J Am Acad Dermatol ; 82(4): 927-935, 2020 Apr.
Article en En | MEDLINE | ID: mdl-31712178
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Cumplimiento de la Medicación / Sustitución de Medicamentos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Cumplimiento de la Medicación / Sustitución de Medicamentos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article